129 related articles for article (PubMed ID: 15982633)
21. The API2/MALT1 fusion product may lead to germinal center B cell lymphomas by suppression of apoptosis.
Stoffel A; Le Beau MM
Hum Hered; 2001; 51(1-2):1-7. PubMed ID: 11096264
[TBL] [Abstract][Full Text] [Related]
22. Mucosa-associated lymphoid tissue lymphoma: molecular pathogenesis and clinicopathological significance.
Inagaki H
Pathol Int; 2007 Aug; 57(8):474-84. PubMed ID: 17610471
[TBL] [Abstract][Full Text] [Related]
23. Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment.
Rosebeck S; Lucas PC; McAllister-Lucas LM
Future Oncol; 2011 May; 7(5):613-7. PubMed ID: 21568677
[TBL] [Abstract][Full Text] [Related]
24. Activation of NF-kappaB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis.
Stoffel A; Chaurushiya M; Singh B; Levine AJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9079-84. PubMed ID: 15184680
[TBL] [Abstract][Full Text] [Related]
25. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.
Remstein ED; Dogan A; Einerson RR; Paternoster SF; Fink SR; Law M; Dewald GW; Kurtin PJ
Am J Surg Pathol; 2006 Dec; 30(12):1546-53. PubMed ID: 17122510
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of the genomic breakpoint junction in the t(11;18) (q21;q21) translocation of a gastric MALT lymphoma.
Sato Y; Akiyama Y; Tanizawa T; Shibata T; Saito K; Mori S; Kamiyama R; Yuasa Y
Biochem Biophys Res Commun; 2001 Jan; 280(1):301-6. PubMed ID: 11162514
[TBL] [Abstract][Full Text] [Related]
27. The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling.
Rosebeck S; Rehman AO; Apel IJ; Kohrt D; Appert A; O'Donnell MA; Ting AT; Du MQ; Baens M; Lucas PC; McAllister-Lucas LM
Oncogene; 2014 May; 33(19):2520-30. PubMed ID: 23770847
[TBL] [Abstract][Full Text] [Related]
28. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.
Griffin BD; Moynagh PN
Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530
[TBL] [Abstract][Full Text] [Related]
29. Production of chemokine CXCL1/KC by okadaic acid through the nuclear factor-kappaB pathway.
Feng G; Ohmori Y; Chang PL
Carcinogenesis; 2006 Jan; 27(1):43-52. PubMed ID: 16000401
[TBL] [Abstract][Full Text] [Related]
30. API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis.
Rosebeck S; Lim MS; Elenitoba-Johnson KS; McAllister-Lucas LM; Lucas PC
World J Biol Chem; 2016 Feb; 7(1):128-37. PubMed ID: 26981201
[TBL] [Abstract][Full Text] [Related]
31. Actvation of NF-kappaB by the API2/MALT1 fusions inhibits p53 dependant but not FAS induced apoptosis: a directional link between NF-kappaB and p53.
Stoffel A; Levine AJ
Cell Cycle; 2004 Aug; 3(8):1017-20. PubMed ID: 15280657
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
33. Auto-ubiquitination-induced degradation of MALT1-API2 prevents BCL10 destabilization in t(11;18)(q21;q21)-positive MALT lymphoma.
Noels H; Somers R; Liu H; Ye H; Du MQ; De Wolf-Peeters C; Marynen P; Baens M
PLoS One; 2009; 4(3):e4822. PubMed ID: 19279678
[TBL] [Abstract][Full Text] [Related]
34. The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes.
Rascle A; Neumann T; Raschta AS; Neumann A; Heining E; Kastner J; Witzgall R
Exp Cell Res; 2009 Jan; 315(1):76-96. PubMed ID: 18996370
[TBL] [Abstract][Full Text] [Related]
35. MALT lymphoma: many roads lead to nuclear factor-κb activation.
Du MQ
Histopathology; 2011 Jan; 58(1):26-38. PubMed ID: 21261681
[TBL] [Abstract][Full Text] [Related]
36. [Detecting the API2-MALT1 fusion gene and its significance in Hashimoto's thyroiditis and thyroid lymphomas].
Yang WX; Li GD; Zhou Q; Liu WP; Li L; Chen N
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):484-7. PubMed ID: 16078567
[TBL] [Abstract][Full Text] [Related]
37. Update on MALT lymphomas.
Isaacson PG
Best Pract Res Clin Haematol; 2005 Mar; 18(1):57-68. PubMed ID: 15694184
[TBL] [Abstract][Full Text] [Related]
38. Oncogene-induced MALT1 protease activity drives posttranscriptional gene expression in malignant lymphomas.
Wimberger N; Ober F; Avar G; Grau M; Xu W; Lenz G; Menden MP; Krappmann D
Blood; 2023 Dec; 142(23):1985-2001. PubMed ID: 37623434
[TBL] [Abstract][Full Text] [Related]
39. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.
Lucas PC; Yonezumi M; Inohara N; McAllister-Lucas LM; Abazeed ME; Chen FF; Yamaoka S; Seto M; Nunez G
J Biol Chem; 2001 Jun; 276(22):19012-9. PubMed ID: 11262391
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional regulation of the human GD3 synthase gene expression in Fas-induced Jurkat T cells: a critical role of transcription factor NF-kappaB in regulated expression.
Kang NY; Kang SK; Lee YC; Choi HJ; Lee YS; Cho SY; Kim YS; Ko JH; Kim CH
Glycobiology; 2006 May; 16(5):375-89. PubMed ID: 16481330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
